Paul Gregor

Amministratore Delegato presso Rimonyx Pharmaceuticals Ltd.

Health Technology

Consumer Services

Government

Posizioni attive di Paul Gregor

Società	Posizione	Inizio	Fine
Rimonyx Pharmaceuticals Ltd. Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel	Amministratore Delegato	01/01/2002	-
	Fondatore	25/11/2009	-

Società	Posizione	Inizio	Fine
W WORL	Direttore Tecnico/Scientifico/R&S	-	-
Bayer Pharmaceuticals Corp.	Corporate Officer/Principal	-	-
National Institutes of Health National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.	Corporate Officer/Principal	-	-
The Salk Institute for Biological Studies	Corporate Officer/Principal	-	-
National Institute on Drug Abuse	Corporate Officer/Principal	-	-

Weizmann Institute of Science

Undergraduate Degree

Distribuzione geografica

Stati Uniti	6
Israele	3

Posizioni

Corporate Officer/Principal	4
Chief Executive Officer	1
Founder	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
W WORL	Health Technology

Aziende private	4
Rimonyx Pharmaceuticals Ltd. Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel	Health Technology
National Institute on Drug Abuse	Government
National Institutes of Health National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.	Government
Bayer Pharmaceuticals Corp.